Search

everythinglearnresearchcommunity

for

Search:↓

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

The folate-cyclodextrin conjugate targets cancer cells more precisely, potentially reducing chemotherapy side effects.

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

Efficient enzyme function relies on specific residue interactions and structural coordination.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

Certain compounds reduced hamster flank organ size by inhibiting 5α-reductase, like finasteride, without affecting androgen receptors.

Peginterferon alpha-2a effectively treats acute hepatitis C in hemodialysed patients, despite some side effects.

Betulinic acid can help treat hepatitis C by stopping virus replication.

CYLD mutations cause a variety of skin tumors with symptoms starting around age 16, and treatments are currently limited.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

The enzyme system in hair follicles is similar to the liver's and is affected by certain inhibitors.

Cyproterone acetate and ethinylestradiol effectively reduce hirsutism and acne in women.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

The medicine Cyclosporin A might cause excessive hair growth by reducing a protein that controls hair growth.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

The NUDT15 gene variant causes severe side effects from azathioprine in some Indian patients.

High doses of cyproterone acetate are linked to an increased risk of developing meningioma.

Certain genetic markers may increase or decrease prostate cancer risk.

Certain mutations in the H6PD gene cause Cortisone Reductase Deficiency by affecting hormone production.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Most European physicians know the risks and safe use of Cyproterone acetate, but few remember receiving official safety communications.

Cyclosporin A, a drug, reduces TGF-β2 expression in skin cells, potentially causing excessive hair growth through a process involving the calcineurin/NFAT pathway.

Finasteride effectively blocks rat enzymes, but with varying methods and strength.

Imatinib mesylate can cause skin lightening, especially in Chinese patients, due to its effect on pigment production.

Diphencyprone initially increases mouse hair growth, then slows it, possibly due to changes in specific protein levels.

Two peptides, RMYYY and VMYMI, may be effective anti-inflammatory drugs.

11β-Hydroxylase inhibitors help prevent seizures in mice by boosting natural neurosteroid production.